OSLER
DEAD

Serial Number

79224188

Owner

Osler Diagnostics Limited

Attorney

Eric Lamb

Filing Date

Oct 26, 2017

Add to watchlist:

No watchlists yet
View on USPTO

OSLER Trademark

Serial Number: 79224188

OSLER is a trademark filed by Osler Diagnostics Limited on October 26, 2017. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 45 (Legal & Security Services), Class 25 (Clothing). The application is currently no longer active.

Owner Contact Info

Osler Diagnostics Limited (12 trademarks)

King Charles House,

Entity Type: 99

Trademark Details

Filing Date

October 26, 2017

Registration Date

Not Registered

Goods & Services

Education, namely, seminars and classes about patient health and wellbeing, training in the field of patient health and wellbeing and research in the field of education; publishing services of books, guides, workbooks, manuals, brochures; publication of medical and/or scientific publications; consultancy, advisory and/or information services relating to or connected with the aforementioned services

Scientific apparatus and instruments, namely, devices for taking and testing blood samples; scientific research and laboratory apparatus and instruments, namely, devices for taking and testing blood samples; material testing apparatus and instruments, namely, devices for taking and testing blood samples; monitoring, measuring, signalling and control apparatus and instruments, namely, devices for taking and testing blood samples; audio-visual apparatus and instruments, namely, screens and devices for displaying diagnostic test results; computer apparatus and instruments, namely, screens and devices for taking and displaying diagnostic test results; software for processing diagnostic test results; application software for taking and displaying diagnostic test results in the field of diagnosing and treating diseases and conditions; data capture, collection, recording, processing, transmission, reproduction, storage and/or communications apparatus and instruments, namely, screens and devices for taking and displaying diagnostic test results; electrical and electronic components, namely, screens and devices for taking and displaying diagnostic test results; structural parts and fittings for all the aforementioned goods

Pharmaceutical preparations for the treatment of autoimmune diseases, allergies and asthma, cancer, Celiac disease, Crohn's and colitis, heart disease, infectious diseases, liver disease, Lupus, Multiple Sclerosis, Relapsing Polychondritis, Rheumatoid Arthritis, Scleroderma, and Diabetes; medical preparations, namely, medicines for the treatment of autoimmune diseases, allergies and asthma, cancer, Celiac disease, Crohn's and colitis, heart disease, infectious diseases, liver disease, Lupus, Multiple Sclerosis, Relapsing Polychondritis, Rheumatoid Arthritis, Scleroderma, and Diabetes; chemical preparations and reagents for medical purposes for the treatment of autoimmune diseases, allergies and asthma, cancer, Celiac disease, Crohn's and colitis, heart disease, infectious diseases, liver disease, Lupus, Multiple Sclerosis, Relapsing Polychondritis, Rheumatoid Arthritis, Scleroderma, and Diabetes; diagnostic preparations, substances, agents, reagents, and assays for medical purposes; diagnostic testing preparations, substances, agents, reagents, and assays for medical purposes

Clothing, namely, shirts, pants, hats, socks; footwear; headwear

Assays and reagents for scientific or medical research purposes

Intellectual property licensing services; licensing of technology; licensing of manufacturing technology and/or manufacturing processes; licensing of intellectual property and/or intellectual property rights; licensing of industrial property and/or industrial property rights; licensing of patents, confidential information, technical information and/or know-how; consultancy, advisory and/or information services relating to or connected with the aforementioned services

Medical services; medical diagnostic services; medical testing, screening and analysis services relating to the diagnosis and/or treatment of disease; consultancy, advisory and/or information services relating to or connected with the aforementioned services

Medical apparatus and instruments, namely, injection and drawing devices for diagnostic testing; medical diagnostic apparatus and instruments, namely, injection and drawing devices; testing apparatus and instruments for medical and/or medical diagnostic purposes, namely, injection and drawing devices; diagnostic testing apparatus and instruments for the measurement of clinical bio markers; structural parts and fittings for all the aforementioned goods

Research and development services in the field of human conditions and diseases; medical research and development services; scientific research and development services; pharmaceutical research and development services; design services in the field of medical and health screening and assessment; research, design and development of medical apparatus and instruments; research, design and development of medical diagnostic apparatus and instruments; research, design and development of diagnostic tests for the measurement of clinical bio markers; software research, design and development services; consultancy, advisory and/or information services relating to or connected with the aforementioned services

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sep 8, 2023 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 8, 2023 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 8, 2023 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 8, 2023 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 8, 2023 COAR
NEW REPRESENTATIVE AT IB RECEIVED
Sep 2, 2023 NREP
FINAL DECISION TRANSACTION PROCESSED BY IB
Apr 24, 2020 FINT
FINAL DISPOSITION NOTICE SENT TO IB
Apr 3, 2020 FICS
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 3, 2020 FICR
NEW REPRESENTATIVE AT IB RECEIVED
Jul 26, 2019 NREP
CHANGE OF NAME/ADDRESS REC'D FROM IB
Jul 5, 2019 ADCH
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Jun 21, 2019 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jun 5, 2019 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jun 5, 2019 OPNR
ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Apr 3, 2019 MAB2
ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Apr 3, 2019 ABN2
NOTIFICATION OF FINAL REFUSAL EMAILED
Sep 5, 2018 GNFN
FINAL REFUSAL E-MAILED
Sep 5, 2018 GNFR
FINAL REFUSAL WRITTEN
Sep 5, 2018 CNFR
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Aug 9, 2018 TCCA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 9, 2018 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 9, 2018 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 9, 2018 TROA
REFUSAL PROCESSED BY IB
Mar 2, 2018 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Feb 9, 2018 RFCS
REFUSAL PROCESSED BY MPU
Feb 9, 2018 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 7, 2018 RFCR
NON-FINAL ACTION WRITTEN
Feb 6, 2018 CNRT
ASSIGNED TO EXAMINER
Feb 5, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Jan 12, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 8, 2018 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jan 4, 2018 REPR